Alxn1850

3 trials 1 recruiting AGastroenterology

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

1 Recruiting

1 Completed trials

1 Sponsors

11 Countries

Phase III

Phase III: 3

Oversight events:

1 serious breach 2 corrective measures across 2 trials

View oversight register →

Sponsors using this IMP

Alexion Pharmaceuticals Inc. 3

All trials

3 total

Phase 3 Study of ALXN1850 in Pediatric Participants with HPP Previously Treated with Asfotase Alfa Revoked

2023-505674-15-00 Phase III 3 countries Alexion Pharmaceuticals Inc.
Phase 3 Study of ALXN1850 in Treatment-Naïve Pediatric Participants with HPP Recruiting

2023-505675-73-00 Phase III 8 countries Alexion Pharmaceuticals Inc.
Phase 3 Study of ALXN1850 versus Placebo in Adolescent and Adult Participants with HPP who have not previously been treated with Asfotase Al… Ended

2023-505673-32-00 Phase III 8 countries Alexion Pharmaceuticals Inc.

Showing 1–3 of 3 trials

← All drugs A–Z